Literature DB >> 26055029

In-Hospital Mortality Following Open and Closed Long Bone Fracture: A Comparative Study.

Adam Adler1, Matthew R Boylan2, Carl Rosenberg3, Robert Pivec1, Bhaveen H Kapadia1, Vidushan Nadarajah1, Qais Naziri1, Steven F Harwin4, Carl B Paulino1.   

Abstract

BACKGROUND: Open fracture is a serious orthopaedic injury that can lead to significant patient morbidity and mortality. There is limited data on the mortality risk for open compared to closed long bone fracture.
METHODS: The Nationwide Inpatient Sample was used to identify all patients who were admitted with a long bone fracture in the United States between 1998 and 2010. Cox proportional hazards regression modeling was used to calculate the hazard ratio (HR) and 95% confidence interval (CI) of mortality.
RESULTS: After adjusting for age, gender, race, insurance, and comorbidities, the HR of mortality was 2.89 (95% CI, 2.56-3.28; p<0.001) for open compared to closed fracture. Stratified by anatomical site, the HR of mortality for open compared to fracture was 3.43 for femur (95% CI, 2.78-4.23; p<0.001), 2.81 for tibia or fibula (95% CI, 2.17-3.64; p<0.001), 2.54 for humerus (95% CI, 1.81-3.56; p<0.001), and 1.56 for radius or ulna (95% CI, 1.10-2.23; p=0.014).
CONCLUSIONS: This data suggests that open fracture carries a worse prognosis compared to closed fracture at the same anatomical site.

Entities:  

Mesh:

Year:  2015        PMID: 26055029

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  2 in total

1.  EPIDEMIOLOGY OF OPEN FRACTURES AND DEGREE OF SATISFACTION OF INITIAL CARE.

Authors:  Filipe Coelho DA Costa; José Mateus Dos Reis; Sérgio Pereira Dos Reis; Lucas Alves Bartelega; Nathan Ferreira DE Melo; Carlos Delano Mundim Araújo
Journal:  Acta Ortop Bras       Date:  2022-08-26       Impact factor: 0.683

2.  Mortality, risk factors and causes of death in Swedish patients with open tibial fractures - a nationwide study of 3, 777 patients.

Authors:  Ulrika Tampe; Lukas W Widmer; Rüdiger J Weiss; Karl-Åke Jansson
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-07-25       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.